1301146-84-8

Basic information

• Product Name: 4-bromo-2-chloro-1-(methoxymethoxy)benzene
• Synonyms: 4-bromo-2-chloro-1-(methoxymethoxy)benzene
• CAS NO: 1301146-84-8
• Molecular Weight: 251.507
• Mol File: 1301146-84-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-bromo-2-chloro-1-(methoxymethoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-chloro-1-(methoxymethoxy)benzene(1301146-84-8)
• EPA Substance Registry System: 4-bromo-2-chloro-1-(methoxymethoxy)benzene(1301146-84-8)

Safety Data

• Hazardous Substances Data: 1301146-84-8(Hazardous Substances Data)

Upstream product

• 3964-56-5 4-bromo-2-chlorophenol 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 1623767-38-3 (R)-1-bromo-3-(3-chloro-4-(methoxymethoxy)phenyl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 
• 1623766-65-3 2-(3-chloro-4-(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1623764-17-9 (R)-3-(3-chloro-4-isopropoxyphenyl)-1-(2,6-dimethylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 
• 1623764-15-7 (R)-3-(3-chloro-4-methoxyphenyl)-1-(2,6-dimethylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 
• 1623764-14-6 (R)-3-(3-chloro-4-(difluoromethoxy)phenyl)-1-(2,6-dimethylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 
• 1623767-40-7 (R)-2-chloro-4-[1-(2,6-dimethylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepin-3-yl]phenol 
• 1623767-39-4 (R)-3-(3-chloro-4-(methoxymethoxy)phenyl)-1-(2,6-dimethylpyridin-4-yl)-6-methyl-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine 

Relevant articles and documents

Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization

Retinoid X receptors (RXRs) play key roles in many physiological processes in both the periphery and central nervous system. In addition, RXRs form heterodimers with other nuclear receptors to exert their physiological effects. The nuclear receptor relate

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.